Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Aquilion ONE Second Generation Launches Advanced Features

By HospiMedica International staff writers
Posted on 19 Mar 2014
Reduced radiation dose, less contrast agent, speedier delivery of results, improved imaging and increased versatility sum up the advantages found on the Aquilion ONE next generation CT scanner from Toshiba Medical systems (Tokyo, Japan). More...
The company presented the latest features including SURESubstraction Lung and Single-Energy Metal Artifact Reduction (SEMAR) at this year’s European Congress Radiology (ECR) meeting.

Joerg Schlegel, Senior Manager, Product Marketing Toshiba discussed the new additions to Aquilion ONE second generation scanner with Medical Imaging International: “Seven years ago we introduced the first version of a volumetric scanner that could acquire a whole organ in a single rotation, but now this second generation outfit has better performance.”

At the ECR 2014, Toshiba launched SEMAR for the first time globally. “This feature enables the visualization of soft tissue around implant, for example hip and knee implants,” explained Mr. Schlegel.

“This is highly significant because the population is aging and many more implants are being conducted making it difficult to evaluate what is going on in tissue around the implant,” he added.

Metal artifacts cause distortions but with SEMAR these distortions are removed from the image providing enhanced visibility of the soft tissue revealing misaligned implants, pseudo-tumors or damage to the implant.

Aquilion ONE has held one of the leading positions in the CT scanner market since its launch in 2007. However, over time Toshiba has worked with customers to refine the product to the latest high specification system. Flexibility and performance take pride of place with the next generation Aquilion ONE with new innovations like Adaptive Diagnostics, including Dual Energy raw data analysis, Variable Helical Pitch, and SEMAR.

Another feature, SURESubtraction Lung, was presented for the first time at the ECR. It runs on Toshiba’s Adaptive Diagnostics software. SURESubstraction Lung technology provides iodine maps of the lung parenchyma with exceptional high contrast-to-noise ratio. “There is a very high contrast-to-noise ratio allowing us to see defects in lung perfusion. This color-coded iodine method is more sensitive than methods currently on the market providing fantastic clinical results,” commented Mr. Schlegel.

The SURESubstraction algorithm has application in other body parts too including subtraction of the skull and medical implants in brain scans; a neck subtraction deformable registration algorithm creates high-resolution images freed of bone structures; and an ortho subtraction ensures accurate subtraction of skeletal structures and calcified plaques.

A study by Mathias Prokop, professor of radiology at Radboud University, Nijmegen, the Netherlands showed that for small perfusion defects, SURESubtraction Lung was far more sensitive.

“This new feature has greatly improved signal and higher spatial resolution compared to iodine maps derived from dual energy acquisitions,” he noted. “SURESubtraction Lung shows perfusion defects and thus provides direct insight in the effect of embolism on lung perfusion. Clinicians find small emboli they could have missed oth¬erwise.”

“It also has enormous unexplored potential, for example with regard to diagnosing the activity of inter¬stitial lung disease, or evaluating the interaction between aeration and perfusion in diseases like emphysema or small airway disease.”

Related Links:
Toshiba Medical Systems



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Adhesive
MED 5570U
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image

Explainable AI Tool Improves Brain Disorder Screening from 4D fMRI

Functional magnetic resonance imaging (fMRI) captures changes in brain activity over time, but the resulting image sequences can be difficult to analyze. Screening for brain disorders requires assessing... Read more

Critical Care

view channel
Image: Liposomes have long been used for gradual drug delivery, with their composition controlling release speed, potency, duration, and potential toxicity. (Image Credit: iStock)

New Drug Delivery System Extends Release of Local Anesthetic for Weeks

Local anesthetics used for nerve blocks often provide pain relief for only a limited period, while perioperative pain can persist much longer. Extending the duration of a nerve block therefore requires... Read more

Surgical Techniques

view channel
Image: Memo 4D Curve preserves the mitral annulus’s natural three-dimensional motion while supporting remodeling and is available in sizes up to 42 mm for a broad range of mitral pathology. (Photo courtesy of Corcym)

First Human Implant Performed With New Open Mitral Annuloplasty Ring

In mitral valve repair, clinicians aim to preserve the mitral annulus’s three-dimensional motion while providing enough support for effective remodeling. Ring preferences vary between open and closed ... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.